Varta
← Back to stories

From The Economic Times

Center-Right Owned by Bennett, Coleman & Co.

Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%

Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%

RSS excerpt

Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology sector recorded significant revenue growth, indicating strong demand for its products. Zaynich received US FDA approval for complicated urinary tract infections…

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →